Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To investigate the efficacy of metoprolol combined with torasemide in elderly patients with degenerative valvular heart disease (DVHD) and heart failure and its influence on N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations.
Methods: The records of 129 DVHD patients ≥60 years old with heart failure diagnosed and treated in our hospital from January 2020 to February 2022 were retrospectively selected. According to the treatment records, 62 patients received metoprolol treatment (Control-group), and 67 patients received metoprolol combined with torasemide treatment (Observation-group). The changes in cardiac function, NT-proBNP and inflammatory factor concentrations and clinical efficacy were analyzed and compared between the two groups before and after treatment.
Results: After treatment, left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD) and the mitral ratio of peak early to late diastolic filling velocity (E/A) were lower, with a greater decrease in the Observation-group compared to the Control-group (<0.05). After treatment, NT-proBNP and interleukin-1beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6) concentrations were lower in both groups, with a greater decrease in the Observation-group compared to the Control-group (<0.05). The total clinical efficacy of the Observation-group was significantly higher than the Control-group (<0.05). There was no significant difference in the total incidence of adverse drug reactions between the two groups (>0.05).
Conclusion: Metoprolol combined with torasemide has a significant therapeutic effect on DVHD patients with heart failure. This drug combination improved cardiac function, reduced NT-proBNP concentrations and has good safety.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364288 | PMC |
| http://dx.doi.org/10.12669/pjms.39.4.7465 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extracorporeal membrane oxygenation combined with prone ventilation for the treatment of high-dose metoprolol and amlodipine poisoning: A case report.
Resusc Plus
November 2025
Department of Emergency Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan 442000 Hubei, China.
Extracorporeal life support (ECLS) represents the ultimate intervention for respiratory and circulatory failure. By maintaining hemodynamic stability, ECLS facilitates drug metabolism and organ recovery, thereby improving survival outcomes. We report a case of severe respiratory and circulatory failure resulting from the oral ingestion of 35 extended-release metoprolol tablets (25 mg each) and 100 extended-release amlodipine tablets (5 mg each).
View Article and Find Full Text PDFMetoprolol exacerbates dementia in scopolamine-induced cognitive impairment in rats: A potential role of NADPH oxidase.
Neuropharmacology
August 2025
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
β-blockers have been implicated in cognitive impairment, with some studies suggesting their role in increasing the risk of vascular dementia (VD). While previous clinical and preclinical research has linked β-blockers, including metoprolol, to cognitive decline, the molecular mechanisms remain unclear. This study aims to elucidate the impact of metoprolol on scopolamine-induced cognitive impairment in rats, focusing on the role of NADPH oxidase-mediated oxidative stress.
View Article and Find Full Text PDFSpectrofluorimetric Method for the Assay of Fixed-Dose Combinations Containing Olmesartan: Sustainability Assessment via Novel Relative Ranking NQS Index, GSST, and Whiteness RGB 12 Model.
Luminescence
August 2025
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.
The Need, Quality, and Sustainability (NQS) index was very recently developed. It evaluates the compromise of analytical techniques between social needs, analytical performance, and global sustainability. Regarding ARBs, Olmesartan (OLM) has become one of the worldwide first-line antihypertensive therapies.
View Article and Find Full Text PDFPredictive factors and pharmacological preventive interventions for atrial fibrillation after aortic valve replacement.
J Cardiothorac Surg
August 2025
Department of Cardiovascular Medicine, Zhongda Hospital Affiliated to Southeast University, Nanjing, 210009, Jiangsu, China.
Objective: This study aims to investigate the predictive factors for postoperative atrial fibrillation (POAF) following aortic valve replacement (AVR) and evaluate the preventive effect of combined atorvastatin and metoprolol therapy on POAF.
Methods: This study employed a mixed design of retrospective cohort analysis and prospective randomized controlled trial, including 268 patients who underwent isolated AVR from January 1, 2022, to March 31, 2024. The 168 patients from January 1, 2022, to May 31, 2023, were analyzed for POAF predictive factors, while 100 patients from June 1, 2023, were included in the prospective trial.
Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients.
BMC Cardiovasc Disord
August 2025
Department of cardiology, No.906 Hospital of PLA Join Logistics Support Force, No. 377, Zhongshan East Road, Ningbo, Zhejiang, 315040, China.
Objective: This study aimed to investigate the impact of amlodipine combined with metoprolol and amlodipine alone on the prognosis of patients with hypertensive heart failure.
Methods: Data were extracted from the MIMIC-IV database. The influence of drug use on patient prognosis was explored by the Chi-square test and Kaplan-Meier analysis.